Risks and Benefits of Long-Term Use of Nicotine Replacement Therapy Products: Public Workshops; Request for Comments

Document ID: FDA-2010-N-0449-0001

Comments

Total: 8
William P George - Comment
Posted : 09/24/2010     ID :FDA-2010-N-0449-0002     Agency : FDA

Dec 27,2010 11:59 PM ET
GlaxoSmithKline Consumer Healthcare - Comment
Posted : 10/25/2010     ID :FDA-2010-N-0449-0003     Agency : FDA

Dec 27,2010 11:59 PM ET
GlaxoSmithKline CH + McNeil CH - Comment
Posted : 10/25/2010     ID :FDA-2010-N-0449-0004     Agency : FDA

Dec 27,2010 11:59 PM ET
Scott D. Ballin, JD - Comment
Posted : 11/10/2010     ID :FDA-2010-N-0449-0005     Agency : FDA

Dec 27,2010 11:59 PM ET
Tiffanie Leistner - Comment
Posted : 11/10/2010     ID :FDA-2010-N-0449-0006     Agency : FDA

Dec 27,2010 11:59 PM ET
Logan Brinkerhoff Wrigley - Comment
Posted : 12/21/2010     ID :FDA-2010-N-0449-0007     Agency : FDA

Dec 27,2010 11:59 PM ET
American Academy of Pediatrics - Comment
Posted : 12/27/2010     ID :FDA-2010-N-0449-0008     Agency : FDA

Dec 27,2010 11:59 PM ET
David Sweanor - Comment
Posted : 12/27/2010     ID :FDA-2010-N-0449-0009     Agency : FDA

Dec 27,2010 11:59 PM ET